EU Passes Landmark AI Act; French Startup’s Language Model Impresses; AI Toys and Legal Rulings Stir Controversy

Date:

What happened with AI this week? Well, the passage of the European Union’s AI Act — a landmark piece of regulation that seeks tackle the potential harms of the AI industry — is a pretty big deal. It could totally reshape how European nations’ relationship to the technology. But a lot of less consequential if no less weird and entertaining stuff happened this week. The French AI startup Mistral released a new large language model and it’s apparently pretty good. Elon Musk’s baby momma (Grimes) may be working on a new plush doll named after Grok, Musk’s annoying AI chatbot. A British court decided that it’s totally cool for a software program to make legal rulings. People are using AI programs to talk to the dead and some researchers think that ChatGPT actually suffers from seasonal depression. In short: regulations or not, the AI industry is definitely going to keep making things weird for everybody for the foreseeable future.

See also  Siri 2.0 Revolution: Apple Set to Unveil AI Breakthroughs at WWDC 2024

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.